The role of Notch as a tumor suppressor in SCLC was established, as in the Rb1/Trp53/Rbl2 background there was a significant reduction of the number of tumors that developed when an activated form of NOTCH1 and NOTCH2 was overexpressed [17]. This evidence concerns the gene RB1 and small cell lung carcinoma.